•Safety and Dose-Response of Vidofludimus Calcium in Relapsing Multiple Sclerosis: Extended Results of a Placebo-Controlled Phase 2 Trial
•Editorial for "Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T"
•Practical Application of Multivendor MRI-Based R2* Mapping for Liver Iron Quantification at 1.5 T and 3.0 T
•Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience
•Increased susceptibility to ischemia causes exacerbated response to microinjuries in the cirrhotic liver